Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;327:811 (4 October), doi:10.1136/bmj.327.7418.811-a
| The first 150 words of the full text of this article appear below. |
EDITORManes et al reported their trial of Helicobacter pylori test and treat v initial proton pump inhibitors.1 Their results in secondary care are encouraging in that eradication treatment for H pylori reduced the relapse of symptoms by 33% compared with a short course of treatment to suppress acid. However, we doubt whether their findings have any relevance to the use of "test and treat" in primary care.
Manes et al used an aggressive investigative strategy of testing, treating, and endoscopy v proton pump inhibitor and endoscopy in patients with dyspepsia who attended a single hospital clinic. All patients in the trial had intensive monthly then two monthly follow up and underwent endoscopy if symptoms recurred after their initial treatment. This would not be usual practice in primary care, where trials have shown that only 25% of young dyspeptic patients undergo endoscopy within a year after consultation.2
In addition,
Brendan C Delaney, reader in primary care
Department of Primary Care and General Practice, University of Birmingham, Birmingham B15 2TT B.C.Delaney@bham.ac.uk
Paul Moayyedi, professor of gastroenterology health services research
Gastroenterology Unit, City Hospital NHS Trust, Birmingham B18 7QH
Richard F A Logan, professor of public health and epidemiology
Department of Public Health and Epidemiology, University Hospital, Nottingham NG7 2UH
Helicobacter pylori positive (CADET-Hp) randomised controlled trial